Literature DB >> 5933417

An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test.

H V Coates, D W Alling, R M Chanock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5933417     DOI： 10.1093/oxfordjournals.aje.a120586

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  89 in total

1.  Ten years of global evolution of the human respiratory syncytial virus BA genotype with a 60-nucleotide duplication in the G protein gene.

Authors:  Alfonsina Trento; Inmaculada Casas; Ana Calderón; Maria L Garcia-Garcia; Cristina Calvo; Pilar Perez-Breña; José A Melero
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

2.  Respiratory syncytial virus that lacks open reading frame 2 of the M2 gene (M2-2) has altered growth characteristics and is attenuated in rodents.

Authors:  H Jin; X Cheng; H Z Zhou; S Li; A Seddiqui
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Natural history of human respiratory syncytial virus inferred from phylogenetic analysis of the attachment (G) glycoprotein with a 60-nucleotide duplication.

Authors:  Alfonsina Trento; Mariana Viegas; Mónica Galiano; Cristina Videla; Guadalupe Carballal; Alicia S Mistchenko; José A Melero
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Variables affecting viral plaque formation in microculture plaque assays using homologous antibody in a liquid overlay.

Authors:  A S Randhawa; G J Stanton; J A Green; S Baron
Journal:  J Clin Microbiol       Date:  1977-05       Impact factor: 5.948

5.  Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate.

Authors:  Bo Liang; Sonja Surman; Emerito Amaro-Carambot; Barbora Kabatova; Natalie Mackow; Matthias Lingemann; Lijuan Yang; Jason S McLellan; Barney S Graham; Peter D Kwong; Anne Schaap-Nutt; Peter L Collins; Shirin Munir
Journal:  J Virol       Date:  2015-07-08       Impact factor: 5.103

6.  Development of a luciferase immunoprecipitation system assay to detect IgG antibodies against human respiratory syncytial virus nucleoprotein.

Authors:  Sangeeta Kumari; Roberta Lynne Crim; Ashwin Kulkarni; Susette A Audet; Thembi Mdluli; Haruhiko Murata; Judy A Beeler
Journal:  Clin Vaccine Immunol       Date:  2014-01-08

7.  The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity.

Authors:  John V Williams; Sharon J Tollefson; Joyce E Johnson; James E Crowe
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 8.  Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

Authors:  V G Hemming; G A Prince; J R Groothuis; G R Siber
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

9.  Intramuscular inoculation of live respiratory syncytial virus induces immunity in cotton rats.

Authors:  G A Prince; L Potash; R L Horswood; E Camargo; S C Suffin; R A Johnson; R M Chanock
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

10.  Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice.

Authors:  J E Crowe; B R Murphy; R M Chanock; R A Williamson; C F Barbas; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.